Back
Speaker illustration

Associate Professor Guliz Kozdag Gold

Montefiore Medical Center, Bronx (United States of America)

Member of:

Heart Failure Association of the ESC

Presentations

The effect of gender on prognosis in patients with sinus rhythm and in patients with atrial fibrillation in heart failure with reduced ejection fraction

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters in chronic heart failure - epidemiology, prognosis, outcome 8

Access
Like
Thumbnail

Albumin is one of the most important prognostic predictors in heart failure with reduced ejection fraction

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters in acute heart failure 2

Access
Like
Thumbnail

Effects of history of stroke on prognosis in advanced stage of chronic systolic heart failure

Event: Heart Failure 2023

Topic: Comorbidities

Session: ePosters in chronic heart failure - comorbidities 2

Access
Like
Thumbnail

Predictors for cardiovascular mortality in patient with history of stroke and advanced stage chronic systolic heart failure

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters in acute heart failure 1

Access
Like
Thumbnail

Prognostic factors for patients with sinus rhythm and patients with atrial fibrillation in heart failure reduced ejection fraction

Event: Heart Failure 2022

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Heart Failure ePosters - focus on Chronic Heart Failure 7

Access
Like
Thumbnail

Predictors of depression in patients with chronic systolic heart failure

Event: Heart Failure 2022

Topic: Comorbidities

Session: Heart Failure ePosters - focus on Chronic Heart Failure 5

Access
Like
Thumbnail

Prognostic importance of glucose levels in patients with diabetes mellitus in advance chronic systolic heart failure

Event: Heart Failure 2022

Topic: Comorbidities

Session: Heart Failure ePosters - focus on Chronic Heart Failure 5

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources